Literature DB >> 2416739

Activation of vitronectin (serum spreading factor) binding of heparin by denaturing agents.

M Hayashi, T Akama, I Kono, H Kashiwagi.   

Abstract

Vitronectin (serum spreading factor), a cell-adhesive glycoprotein present in mammalian serum, has previously been the subject of conflicting reports concerning its binding to heparin. Vitronectin purified from human plasma does not bind to heparin under physiological conditions, but it does so after treatment with denaturing agents including 8 M urea or 6 M guanidine-HC1, or heating at 100 degrees C for 5 min. These treatments seem to expose a heparin-binding site in vitronectin; this finding thus resolves the conflicts concerning this function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416739     DOI: 10.1093/oxfordjournals.jbchem.a135363

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis.

Authors:  T D Duensing; J S Wing; J P van Putten
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Vitronectin-binding staphylococci enhance surface-associated complement activation.

Authors:  F Lundberg; T Lea; A Ljungh
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies.

Authors:  Z Gechtman; A Belleli; S Lechpammer; S Shaltiel
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 4.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

5.  Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.

Authors:  L Milis; C A Morris; M C Sheehan; J A Charlesworth; B A Pussell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

6.  Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells.

Authors:  Claudia Sa E Cunha; Natalie J Griffiths; Mumtaz Virji
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

7.  New insights into heparin binding to vitronectin: studies with monoclonal antibodies.

Authors:  P Anne Underwood; Alan Kirkpatrick; Sue M Mitchell
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

8.  Vitronectin binds to the gonococcal adhesin OpaA through a glycosaminoglycan molecular bridge.

Authors:  T D Duensing; J P Putten
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

9.  Ca2(+)-sensitive binding of thrombospondin to U937 cells is due to the formation of calcium precipitate in the binding medium.

Authors:  X Sun; D F Mosher
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

10.  The streptococcal collagen-binding protein CNE specifically interferes with alphaVbeta3-mediated cellular interactions with triple helical collagen.

Authors:  Tijs van Wieringen; Sebastian Kalamajski; Asa Lidén; Dominique Bihan; Bengt Guss; Dick Heinegård; Richard W Farndale; Kristofer Rubin
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.